Figure 2
Figure 2. Cumulative incidences of response in dasatinib and imatinib arms. (A) Complete cytogenetic response. (B) Major molecular response. (C) BCR-ABL transcript level reduction to ≤ 0.0032%. CCyR indicates complete cytogenetic response; and MMR, major molecular response.

Cumulative incidences of response in dasatinib and imatinib arms. (A) Complete cytogenetic response. (B) Major molecular response. (C) BCR-ABL transcript level reduction to ≤ 0.0032%. CCyR indicates complete cytogenetic response; and MMR, major molecular response.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal